We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.32B
AUM Growth
+$456M
Cap. Flow
+$224M
Cap. Flow %
3.55%
Top 10 Hldgs %
17.62%
Holding
844
New
72
Increased
349
Reduced
257
Closed
60

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$37.6M
2
BMY icon
Bristol-Myers Squibb
BMY
+$29.3M
3
BIIB icon
Biogen
BIIB
+$27.4M
4
HD icon
Home Depot
HD
+$22.7M
5
CSCO icon
Cisco
CSCO
+$21.1M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$23.6M
2
TJX icon
TJX Companies
TJX
+$19.3M
3
FDX icon
FedEx
FDX
+$16.4M
4
INTU icon
Intuit
INTU
+$14.7M
5
GLW icon
Corning
GLW
+$13.3M

Sector Composition

Rank Sector Weight
1 Healthcare 25.18%
2 Technology 17.19%
3 Financials 12.85%
4 Consumer Discretionary 10.2%
5 Communication Services 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBRE icon
76
CBRE Group
CBRE
$40.8B
$19.6M 0.31%
410,345
-31,748
-7% -$1.5M
ELV icon
77
Elevance Health
ELV
$81.9B
$19.3M 0.31%
81,128
-1,928
-2% -$446K
FTV icon
78
Fortive
FTV
$19B
$19.2M 0.3%
395,390
+149,016
+60% +$7.12M
DFS
79
DELISTED
Discover Financial Services
DFS
$19.1M 0.3%
270,794
-56,801
-17% -$4.17M
IBM icon
80
IBM
IBM
$202B
$18.2M 0.29%
136,314
+10,832
+9% +$1.51M
INTU icon
81
Intuit
INTU
$81.1B
$18M 0.29%
88,239
-76,874
-47% -$14.7M
SHW icon
82
Sherwin-Williams
SHW
$78.3B
$18M 0.28%
132,165
+87,546
+196% +$11.3M
AMD icon
83
Advanced Micro Devices
AMD
$851B
$17.6M 0.28%
1,172,277
+126,122
+12% +$1.6M
UNP icon
84
Union Pacific
UNP
$183B
$17.5M 0.28%
123,810
+10,210
+9% +$1.42M
IMMU
85
DELISTED
Immunomedics Inc
IMMU
$17.5M 0.28%
738,000
+141,000
+24% +$2.83M
HPE icon
86
Hewlett Packard
HPE
$63.2B
$17.3M 0.27%
1,183,565
+392,021
+50% +$6.5M
NTAP icon
87
NetApp
NTAP
$32.9B
$17.3M 0.27%
220,056
+80,530
+58% +$5.66M
DGX icon
88
Quest Diagnostics
DGX
$25.1B
$17M 0.27%
154,741
-24,450
-14% -$2.55M
TSRO
89
DELISTED
TESARO, Inc.
TSRO
$17M 0.27%
381,500
+89,000
+30% +$4.32M
DD icon
90
DuPont de Nemours
DD
$18.6B
$16.8M 0.27%
100,870
-49,296
-33% -$8.25M
PEP icon
91
PepsiCo
PEP
$186B
$16.6M 0.26%
152,133
-1,916
-1% -$198K
LOW icon
92
Lowe's Companies
LOW
$116B
$16.5M 0.26%
172,446
-31,864
-16% -$2.88M
PGR icon
93
Progressive
PGR
$124B
$16.4M 0.26%
276,430
+111,511
+68% +$6.83M
MET icon
94
MetLife
MET
$61B
$16.3M 0.26%
374,162
+189,093
+102% +$8.82M
MO icon
95
Altria Group
MO
$122B
$15.6M 0.25%
274,676
-124,084
-31% -$7.16M
HES
96
DELISTED
Hess
HES
$15.6M 0.25%
232,561
+2,580
+1% +$154K
KO icon
97
Coca-Cola
KO
$354B
$15.5M 0.25%
354,432
-172,394
-33% -$7.45M
IRBT
98
DELISTED
iRobot
IRBT
$15.5M 0.24%
204,224
+31,322
+18% +$2.08M
EBAY icon
99
eBay
EBAY
$48.6B
$15M 0.24%
413,414
+147,076
+55% +$5.72M
EC icon
100
Ecopetrol
EC
$32.9B
$14.9M 0.24%
726,000
+26,000
+4% +$551K

Similar funds

Candriam SCA's Q2 2018 Portfolio in Review

As of Q2 2018, Candriam SCA held 844 positions worth $6.32B, up 7.8% from $5.86B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA deployed $224M of net new capital in Q2 2018, opening 72 new positions and adding to 349 existing holdings. Its largest new stake was Broadcom: 1,532,450 shares worth $37.2M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $23.6M trimmed.

  • Candriam SCA's largest Q2 2018 buy was Broadcom: 1,532,450 shares worth $37.2M.
  • Candriam SCA added most to Bristol-Myers Squibb in Q2 2018, an estimated $29.3M increase.
  • Candriam SCA's biggest Q2 2018 reduction was JPMorgan Chase, cutting an estimated $23.6M.
  • Candriam SCA fully exited Monsanto Co in Q2 2018, selling an estimated $11.5M.
  • Candriam SCA's ten largest holdings make up 18% of its $6.32B portfolio in Q2 2018.
  • Candriam SCA opened 72 new positions and closed 60 in Q2 2018.
  • Candriam SCA's portfolio value rose 7.8% quarter-over-quarter to $6.32B.

Based on Candriam SCA's 13F filing for Q2 2018, filed 14 Aug 2018.